Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: Report of 12 cases and review of the literature

Clinical Infectious Diseases

Volumn 34, Issue 6, 2002, Pages 838-846

  Falcó, Vicente ^a   Rodríguez, Dolors ^a   Ribera, Esteban ^a   Martínez, Esteban ^c   Miró, José Maria ^c   Domingo, Pere ^b   Diazaraque, Ruth ^d   Arribas, José R ^d   González García, Juan J ^d   Montero, Francesc ^b   Sánchez, Lluis ^a   Pahissa, Albert ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; INDINAVIR; LACTIC ACID; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; NUCLEOSIDE DERIVATIVE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTIC ACIDOSIS; MALE; METABOLIC ACIDOSIS; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS;

ACIDOSIS, LACTIC; ADULT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; MULTIVARIATE ANALYSIS; PROGNOSIS; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0037087075     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/339041     Document Type: Article

References (51)

1. Fulminant hepatic failure associated with 2′,3′-dideoxyinosine (ddI)
2. Severe lactic acidosis induced by nucleoside analogues in an HIV-infected man
3. Lactic acidosis and hepatic steatosis associated with use of stavudine: Report of four cases
4. Hepatomegaly with severe steatosis in HIV-seropositive patients
5. Fulminant hepatitis with severe lactic acidosis in HIV-infected patients on didanosine therapy
6. Massive hepatic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine
7. Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy
8. Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: A case report
9. Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: Report of two patients and review of the literature
10. Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as a common pathway
11. Hyperlactatemia in HIV-infected patients: The role of NRTI treatment
12. Editorial response: Hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue transcriptase inhibitors
13. Management of hyperlactatemia: No need for routine lactate measurements
14. Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens
15. Lactic acidosis complicating the acquired immunodeficiency syndrome
16. Lactic acidosis and AIDS
17. Lactic acidosis and AIDS
18. Lactic acidosis and AIDS
19. Lactic acidosis in HIV-infected patients
20. Type B lactic acidosis in an AIDS patient treated with zidovudine
21. Beri-beri and thiamine deficiency in HIV infection
22. Lactic acidosis and hepatic mitochondrial changes during treatment with zidovudine
23. Riboflavin to treat nucleoside analogue induced lactic acidosis
24. Fatal lactic acidosis in a patient with acquired immunodeficiency syndrome treated with stavudine, lamivudine and indinavir
25. Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion
26. Zidovudine-associated type B lactic acidosis and hepatic steatosis in an HIV-infected patient
27. Riboflavine and severe lactic acidosis
28. Thiamine for the treatment of nucleoside analogue-induced severe lactic acidosis
29. Acute pancreatitis with severe lactic acidosis in an HIV-infected patient on didanosine therapy
30. Survival of a human immunodeficiency patient with nucleoside induced lactic acidosis: Role of a haemodilyasis treatment
31. Lactic acidosis associated with stavudine administration: A report of five cases
32. Lactic acidosis secondary to nucleoside analog antiretroviral therapy
33. Fatal lactic acidosis and liver steatosis associated with didanosine and stavudine treatment: A respiratory chain dysfunction?
34. Symptomatic hyperlactataemia: An emergency complication of antiretroviral therapy
35. Lactic acidosis type B. A life-threatening adverse effect of antiretroviral therapy
36. L-carnitine as a treatment of life-threatening lactic acidosis induced by nucleoside analogues
37. Acidose lactique fatale chez une patiente infectée par le VIH et traitée par stavudine et didanosine
38. Acute pancreatitis associated with severe lactic acidosis in human immunodeficiency virus-infected patients receiving triple therapy
39. Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 Fatal cases
40. Large hepatic mitochondrial DNA deletions associated with L-lactic acidosis and highly active antiretroviral therapy
41. Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: Lactic acidosis, risk factors and therapeutic options
42. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity
43. Incorporation of selected nucleoside phosphonates and anti-human immunodeficiency virus nucleotide analogues into DNA by human DNA polymerases α, β and γ
44. Clinical, virologic and immunologic significance of lactic acid levels in HIV positive adults
45. Elevations of plasma lactic acid in HIV patients receiving nucleoside reverse transcriptase inhibitors
46. A syndrome of lypoatrophy, lactic acidemia and liver dysfunction associated with HIV nucloside analogue therapy: Contribution to protease inhibitor-related lipodystrophy syndrome
47. Fulminant neuropathy and lactic acidosis associated with nucleoside analog therapy
48. Lactate concentrations distinguish between nucleoside neuropathy and HIV distal symmetrical sensory polyneuropathy
49. Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy
50. Acidose lactique et défaillance multiviscérale secondaire aux thérapeutiques antirétrovirales chez les patients infectés par le VIH